REPORT FROM THE AAN, APRIL 10-17, 2010 – The following is a summary of recent medication studies presented at AAN 2010.
Neurology
Twice-weekly glatiramer acetate as effective as daily dosing
June 2, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – A new U.S. study reports that glatiramer acetate administered twice per week is as effective as daily dosing (Caon et al. AAN, S11.002).
Hypertension and dementia risk differs in the very elderly
June 2, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – Hypertension is well established as a dementia risk factor, but two analyses from the 90+ trial indicate that it is not associated with dementia in the very old.
CCSVI: an update
June 2, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – Over 4,000 MS patients signed on to the National MS Society press conference and webinar on chronic cerebrospinal venous insufficiency (CCSVI), held April 14th, 2010, during the AAN annual meeting (See Special Report: CCSVI, NeuroSens, February 17, 2010).
Beta-interferons and glatiramer acetate: data at 15 years
May 26, 2010Disease-modifying therapies used in MS appear to be generally safe after long-term use, according to 15-year results from two new studies.